Characterization of Wnt/β‐catenin signalling in osteoclasts in multiple myeloma
Authors:
Open Access
- 9 February 2010
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 148 (5) , 726-738
Abstract
Summary: We recently showed that increasing Wnt/β‐catenin signalling in the bone marrow microenvironment or in multiple myeloma (MM) cells clearly suppresses osteoclastogenesis in SCID‐hu mice; however, this regulation of osteoclastogenesis could result directly from activation of Wnt/β‐catenin signalling in osteoclasts or indirectly from effects on osteoblasts. The present studies characterized Wnt/β‐catenin signalling and its potential role in osteoclasts. Systematic analysis of expression of WNT, FZD, LRP and TCF gene families demonstrated that numerous Wnt‐signalling components were expressed in human osteoclasts from patients with MM. Functional Wnt/β‐catenin signalling was identified by accumulation of total and active β‐catenin and increases in Dvl‐3 protein in response to Wnt3a or LiCl. Furthermore, Wnt‐induced increases in β‐catenin and Dvl‐3 were attenuated by Wnt antagonists Dkk1 and sFRP1. Finally, Wnt3a‐induced TCF/LEF transcriptional activity suggests that canonical Wnt signalling is active in osteoclasts. Supernatants from dominant‐negative‐β‐catenin–expressing osteoblast clones significantly stimulated tartrate‐resistant acid phosphatase–positive osteoclast formation from primary MM‐derived osteoclasts, compared with supernatants from control cells. These results suggested that Wnt/β‐catenin signalling is active in osteoclasts in MM and is involved in osteoclastogenesis in bone marrow, where it acts as a negative regulator of osteoclast formation in an osteoblast‐dependent manner in MM.Keywords
This publication has 47 references indexed in Scilit:
- WNT/β-Catenin Signaling Is Involved in Regulation of Osteoclast Differentiation by Human Immunodeficiency Virus Protease Inhibitor RitonavirThe American Journal of Pathology, 2009
- Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growthBlood, 2008
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myelomaBlood, 2008
- The pathogenesis of the bone disease of multiple myelomaBone, 2008
- Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivoBlood, 2006
- Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast DifferentiationDevelopmental Cell, 2005
- Wnt signaling in B and T lymphocytesFrontiers in Bioscience-Landmark, 2004
- MECHANISMS OF WNT SIGNALING IN DEVELOPMENTAnnual Review of Cell and Developmental Biology, 1998
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996